Cellular Biomedicine Inc logo

CBMG - Cellular Biomedicine Inc News Story

$18.11 0.2  1.3%

Last Trade - 15/01/21

Sector
Healthcare
Size
Small Cap
Market Cap £259.6m
Enterprise Value £275.7m
Revenue £238k
Position in Universe 3633rd / 6547

BRIEF-Cellular Biomedicine Group's First Clinical Data Of IIT Phase 1 Trial Of C-Car088

Sat 7th December, 2019 4:44pm
Dec 7 (Reuters) - Cellular Biomedicine Group Inc  CBMG.O :
    * CELLULAR BIOMEDICINE GROUP PRESENTS FIRST CLINICAL DATA OF
IIT
PHASE 1 TRIAL OF C-CAR088, A NOVEL BCMA CAR-T, AT THE 61ST
ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY
    * CELLULAR BIOMEDICINE GROUP-FIVE PATIENTS INCLUDED IN
ANALYSIS;
ALL FIVE SHOWED CLINICAL IMPROVEMENT IN AS EARLY AS TWO WEEKS

Source text for Eikon:  ID:nPn8V06DGa 
Further company coverage:  CBMG.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.